Huang Z - Search Results

1

Stratification of patients with KRAS-mutated advanced non-small cell lung cancer: improving prognostics.

Zhang Y, Zeng F, Peng S, Chen Y, Jiang W, Wang Z, Deng L, Huang Z, Qin H, Yan H, Zhang X, Zhang L, Yang N, Gong Q, Zeng L, Zhang Y. Zhang Y, et al. Among authors: huang z. Expert Rev Respir Med. 2023 Jul-Dec;17(9):743-751. doi: 10.1080/17476348.2023.2265810. Epub 2023 Oct 27. Expert Rev Respir Med. 2023. PMID: 37776047

2

[Determination of organophosphorus pesticide multi-residues in tea by gas chromatography].

Zhang Y, Huang ZQ, Li YJ. Zhang Y, et al. Among authors: huang zq. Se Pu. 2001 May;19(3):273-5. Se Pu. 2001. PMID: 12541817 Chinese.

3

Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements.

Zhang Y, Huang Z, Zeng L, Zhang X, Li Y, Xu Q, Yang H, Lizaso A, Xu C, Liu J, Wang W, Song Z, Ou SI, Yang N. Zhang Y, et al. Among authors: huang z. NPJ Precis Oncol. 2022 Mar 31;6(1):20. doi: 10.1038/s41698-022-00264-w. NPJ Precis Oncol. 2022. PMID: 35361870 Free PMC article.

4

PD-1 inhibitor versus bevacizumab in combination with platinum-based chemotherapy for first-line treatment of advanced lung adenocarcinoma: A retrospective-real world study.

Huang Z, Zhou C, Xiong Y, Yang F, Zeng F, Jiang W, Zhang Y, Yang H, Liu L, Zeng L, Yang N, Wang Z. Huang Z, et al. Front Oncol. 2022 Nov 9;12:909721. doi: 10.3389/fonc.2022.909721. eCollection 2022. Front Oncol. 2022. PMID: 36439441 Free PMC article.

5

Iris metastasis as resistance mechanism to atezolizumab, carboplatin, and etoposide but responds to additional irinotecan and anlotinib in a small cell lung cancer patient.

Huang Z, Zhang Y. Huang Z, et al. Thorac Cancer. 2023 Mar;14(8):779-782. doi: 10.1111/1759-7714.14818. Epub 2023 Feb 6. Thorac Cancer. 2023. PMID: 36747371 Free PMC article.

6

Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With ROS1-Rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort Study.

Huang Z, Yan H, Zeng L, Xu Q, Guo W, Lin S, Jiang W, Wang Z, Deng L, Qin H, Zhang X, Tong F, Zhang R, Liu Z, Zhang L, Dong X, Yang N, Zhang Y. Huang Z, et al. JCO Precis Oncol. 2023 Mar;7:e2200614. doi: 10.1200/PO.22.00614. JCO Precis Oncol. 2023. PMID: 36952645

7

Clinical activity of pembrolizumab with or without chemotherapy in advanced pulmonary large-cell and large-cell neuroendocrine carcinomas: a multicenter retrospective cohort study.

Song L, Zhou F, Xu T, Zeng L, Xia Q, Wang Z, Deng L, Li Y, Qin H, Yan H, Huang Z, Mi J, Xu Q, Yang N, Zhou C, Zhang Y. Song L, et al. Among authors: huang z. BMC Cancer. 2023 May 16;23(1):443. doi: 10.1186/s12885-023-10952-w. BMC Cancer. 2023. PMID: 37189075 Free PMC article.

8

Intracranial activity of first-line immune checkpoint inhibitors combined with chemotherapy in advanced non-small cell lung cancer.

Huang Z, Wu F, Xu Q, Song L, Zhang X, Wang Z, Deng L, Zhang Y, Zeng L, Yang N. Huang Z, et al. Chin Med J (Engl). 2023 Jun 20;136(12):1422-1429. doi: 10.1097/CM9.0000000000002720. Epub 2023 May 17. Chin Med J (Engl). 2023. PMID: 37195128 Free PMC article.

9

Dynamic cytokines signature predicts survival outcome from severe Immune-related hepatitis with PD-1/PD-L1 blockade in lung cancer.

Zeng L, Zhou Y, Xu Q, Huang Z, Song L, Wang Z, Deng L, Wu Y, Liang Y, Liu Z, Gao X, Yi X, He Q, Xia X, Yang H, Zhang X, Yan H, Qin H, Lin S, Yang N, Zhang Y. Zeng L, et al. Among authors: huang z. Lung Cancer. 2023 Oct;184:107350. doi: 10.1016/j.lungcan.2023.107350. Epub 2023 Aug 28. Lung Cancer. 2023. PMID: 37659241

10

Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.

Yan H, Song L, Li Y, Xu Q, Guo W, Lin S, Jiang W, Wang Z, Deng L, Huang Z, Qin H, Zhang X, Tong F, Zhang R, Liu Z, Zhang L, Yu J, Dong X, Gong Q, Deng J, Chen X, Wang J, Zhang G, Yang N, Zhang Y, Zeng L. Yan H, et al. Among authors: huang z. Cancer Immunol Immunother. 2024 Mar 7;73(4):74. doi: 10.1007/s00262-024-03660-2. Cancer Immunol Immunother. 2024. PMID: 38451314 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,775 results

Search Page

Filters